SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-041368
Filing Date
2017-08-09
Accepted
2017-08-09 06:02:49
Documents
4
Period of Report
2017-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v472777_8k.htm 8-K 22183
2 EXHIBIT 10.1 v472777_ex10-1.htm EX-10.1 18352
3 EXHIBIT 99.1 v472777_ex99-1.htm EX-99.1 192574
4 GRAPHIC logo.jpg GRAPHIC 24124
  Complete submission text file 0001144204-17-041368.txt   267402
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 171016307
SIC: 2834 Pharmaceutical Preparations